Pulmonx Corporation (LUNG) financial statements (2022 and earlier)

Company profile

Business Address 700 CHESAPEAKE DRIVE
REDWOOD CITY, CA 94063
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments180,041231,561
Cash and cash equivalents148,480231,561
Short-term investments31,561 
Receivables6,9244,567
Inventory, net of allowances, customer advances and progress billings16,28510,741
Inventory16,28510,741
Prepaid expense4,1742,512
Other current assets347377
Other undisclosed current assets231231
Total current assets:208,002249,989
Noncurrent Assets
Operating lease, right-of-use asset8,0758,976
Property, plant and equipment4,8141,474
Long-term investments and receivables10,941 
Long-term investments10,941 
Intangible assets, net (including goodwill)2,6102,733
Goodwill2,3332,333
Intangible assets, net (excluding goodwill)277400
Other noncurrent assets731536
Total noncurrent assets:27,17113,719
TOTAL ASSETS:235,173263,708
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14,94810,123
Accounts payable1,5821,472
Accrued liabilities13,3668,651
Deferred revenue16371
Debt91 
Other undisclosed current liabilities2,3482,332
Total current liabilities:17,55012,526
Noncurrent Liabilities
Long-term debt and lease obligation7,4788,182
Long-term debt, excluding current maturities634564
Operating lease, liability6,8447,618
Liabilities, other than long-term debt3762
Deferred income tax liabilities3762
Other undisclosed noncurrent liabilities16,86916,804
Total noncurrent liabilities:24,38425,048
Total liabilities:41,93437,574
Stockholders' equity
Stockholders' equity attributable to parent193,239226,134
Common stock3736
Additional paid in capital482,885467,147
Accumulated other comprehensive income1,7121,685
Accumulated deficit(291,395)(242,734)
Total stockholders' equity:193,239226,134
TOTAL LIABILITIES AND EQUITY:235,173263,708

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
Revenues48,41632,733
Cost of revenue
(Cost of Goods and Services Sold)
(12,786)(11,531)
Gross profit:35,63021,202
Operating expenses(82,934)(53,534)
Operating loss:(47,304)(32,332)
Nonoperating income (expense)(185)3,495
Investment income, nonoperating400213
Other nonoperating income (expense)(585)3,282
Interest and debt expense(829)(3,181)
Loss from continuing operations before income taxes:(48,318)(32,018)
Income tax expense(343)(213)
Net loss available to common stockholders, diluted:(48,661)(32,231)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
Net loss:(48,661)(32,231)
Comprehensive loss:(48,661)(32,231)
Other undisclosed comprehensive income, net of tax, attributable to parent27312
Comprehensive loss, net of tax, attributable to parent:(48,634)(31,919)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: